Kyverna Therapeutics Inc (KYTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 0 | 37,735 |
| Marketable Securities | 0 | 13,587 |
| Other current assets | 0 | 1,929 |
| TOTAL | $0 | $53,251 |
| Non-Current Assets | ||
| PPE Net | N/A | 4,193 |
| Other Non-Current Assets | 0 | 2,884 |
| TOTAL | $N/A | $7,077 |
| Total Assets | $0 | $66,924 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 0 | 1,451 |
| Accrued Expenses | 0 | 7,661 |
| Other current liabilities | 0 | 565 |
| TOTAL | $0 | $11,954 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 0 | 120,680 |
| TOTAL | $N/A | $121,758 |
| Total Liabilities | $0 | $140,921 |
| Shareholders' Equity | ||
| Retained earnings | 0 | -75,677 |
| Other shareholders' equity | 0 | -26 |
| TOTAL | $0 | $-73,997 |
| Total Liabilities And Equity | $0 | $66,924 |